Mystery infections in healthy people: scientists investigate
NCT ID NCT00814827
First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 9 times
Summary
This study looks at HIV-negative people who get opportunistic infections—illnesses that usually only affect those with weak immune systems. Researchers want to find out if these patients have unusual antibodies that block a key immune signal. Up to 224 adults in Thailand and Taiwan will be followed for two years to understand why their bodies can't fight off certain germs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help identify why some otherwise healthy people get serious infections, potentially leading to better diagnosis or targeted treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly lead to new therapies, and findings may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BURKHOLDERIA PSEUDOMALLEI INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cheng Kung University
Tainan, Taiwan
-
National Siriraj Hospital, Mahidol Universtiy
Bangkok, Thailand
-
National Taiwan University
Taiwan, China
-
Ramathibodi Hospital, Mahidol Universtiy
Bangkok, Thailand
-
Srinagarind Hospital
Khon Kaen, 40002, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new patient cohort unlock the secrets of TB treatment success?
- Shorter TB treatment: a 4-Month regimen put to the test
- Lung damage after TB: a new study tests whether rehabilitation can restore breathing and quality of life
- Can a more powerful antibiotic clear TB faster? a trial puts rifapentine to the test.
- Could a simple screening strategy uncover hidden TB in COPD patients?
- Talking it out: could counseling be the key to beating TB?